VC DEALS ANALYSIS: 2016 Bucks January Trend With Flying Start
This article was originally published in Clinica
January is traditionally a slow month for venture funding deals but 2016 is already distinguishing itself from the previous years with total deal value exceeding well above $600m in the first month.
You may also be interested in...
2017 has not got off to a bullish start, with January’s total venture financing deal value barely making it half way past last year’s level. The biggest round, at $40m, went to preterm birth risk specialist Sera Prognostics, catching the eye of the largest lab services provider in the US, LabCorp.
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.